• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Similar Metabolic Profile Between the Failing Myocardium and Tumor Could Provide Alternative Therapeutic Targets in Chemotherapy-Induced Cardiotoxicity.

作者信息

Saleme Bruno, Sutendra Gopinath

机构信息

Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.

出版信息

Front Cardiovasc Med. 2018 Jun 11;5:61. doi: 10.3389/fcvm.2018.00061. eCollection 2018.

DOI:10.3389/fcvm.2018.00061
PMID:29951485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6008528/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/6008528/2e7a4011ad9e/fcvm-05-00061-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/6008528/2e7a4011ad9e/fcvm-05-00061-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c5/6008528/2e7a4011ad9e/fcvm-05-00061-g0001.jpg

相似文献

1
A Similar Metabolic Profile Between the Failing Myocardium and Tumor Could Provide Alternative Therapeutic Targets in Chemotherapy-Induced Cardiotoxicity.衰竭心肌与肿瘤之间相似的代谢特征可为化疗所致心脏毒性提供替代性治疗靶点。
Front Cardiovasc Med. 2018 Jun 11;5:61. doi: 10.3389/fcvm.2018.00061. eCollection 2018.
2
Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.心脏肿瘤学：对蒽环类药物、人表皮生长因子受体2抑制剂及放疗所致心脏毒性与管理的重点综述
Ochsner J. 2016 Fall;16(3):250-6.
3
Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.心脏肿瘤学概念：癌症治疗引起的心脏毒性的定义、机制、诊断和治疗策略
Future Oncol. 2016 Mar;12(6):855-70. doi: 10.2217/fon.15.349. Epub 2016 Feb 1.
4
Pharmacological foundations of cardio-oncology.心脏肿瘤药理学基础。
J Pharmacol Exp Ther. 2010 Jul;334(1):2-8. doi: 10.1124/jpet.110.165860. Epub 2010 Mar 24.
5
Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.心脏肿瘤学：一种用于癌症患者心脏功能障碍检测、预防和管理的多学科方法。
Jpn J Clin Oncol. 2017 Aug 1;47(8):678-682. doi: 10.1093/jjco/hyx068.
6
Role of Imaging in Cardio-Oncology.影像学在心脏肿瘤学中的作用。
Curr Treat Options Cardiovasc Med. 2017 Jun;19(6):46. doi: 10.1007/s11936-017-0546-2.
7
Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy.在衰竭心肌中，心肌转录因子mRNA水平升高：猪模型和人类扩张型心肌病中的表达谱分析
J Mol Med (Berl). 2003 Sep;81(9):566-77. doi: 10.1007/s00109-003-0470-7. Epub 2003 Aug 13.
8
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.血管内皮生长因子-B基因疗法通过内皮保护作用抑制阿霉素诱导的心脏毒性。
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13144-13149. doi: 10.1073/pnas.1616168113. Epub 2016 Oct 31.
9
Organization and implementation of a cardio-oncology program.心脏肿瘤项目的组织与实施
Rev Port Cardiol. 2016 Sep;35(9):485-94. doi: 10.1016/j.repc.2016.04.006. Epub 2016 Aug 5.
10
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.PKM2 通过依赖于氧化还原的方式对 p53 进行组织特异性调节，为蒽环类抗生素诱导的心脏毒性提供了一个治疗靶点。
Sci Transl Med. 2019 Feb 6;11(478). doi: 10.1126/scitranslmed.aau8866.

引用本文的文献

1
Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.用于疾病建模和药物测试的组织芯片与微生理系统
Micromachines (Basel). 2021 Jan 28;12(2):139. doi: 10.3390/mi12020139.
2
How Hypertension Affects Heart Metabolism.高血压如何影响心脏代谢。
Front Physiol. 2019 Apr 16;10:435. doi: 10.3389/fphys.2019.00435. eCollection 2019.

本文引用的文献

1
Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.在化疗迟发效应的小鼠模型中，环磷酰胺会导致身体机能和体内线粒体功能出现持续性缺陷。
PLoS One. 2017 Jul 10;12(7):e0181086. doi: 10.1371/journal.pone.0181086. eCollection 2017.
2
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.加拿大心血管学会癌症治疗相关心血管并发症的评估与管理指南。
Can J Cardiol. 2016 Jul;32(7):831-41. doi: 10.1016/j.cjca.2016.02.078. Epub 2016 Apr 7.
3
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
心脏毒性的途径：化疗药物阿霉素和米托蒽醌之间的比较。
Arch Toxicol. 2016 Sep;90(9):2063-2076. doi: 10.1007/s00204-016-1759-y. Epub 2016 Jun 25.
4
Cost-effectiveness of strain-targeted cardioprotection for prevention of chemotherapy-induced cardiotoxicity.针对特定菌株的心脏保护在预防化疗所致心脏毒性方面的成本效益。
Int J Cardiol. 2016 Jun 1;212:336-45. doi: 10.1016/j.ijcard.2016.02.137. Epub 2016 Mar 9.
5
The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity.抗癌药物代谢在其所致心脏毒性中的作用。
Curr Drug Metab. 2015;17(1):75-90. doi: 10.2174/1389200216666151103114926.
6
Drug-induced mitochondrial dysfunction and cardiotoxicity.药物诱导的线粒体功能障碍和心脏毒性。
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67. doi: 10.1152/ajpheart.00554.2015. Epub 2015 Sep 18.
7
Cardiotoxicity of anticancer treatments.抗癌治疗的心脏毒性。
Nat Rev Cardiol. 2015 Nov;12(11):620. doi: 10.1038/nrcardio.2015.133. Epub 2015 Aug 20.
8
Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).压力超负荷致左、右心衰竭中心脏能量代谢改变（2013 年 Grover 会议系列）。
Pulm Circ. 2015 Mar;5(1):15-28. doi: 10.1086/679608.
9
A PKM2 signature in the failing heart.衰竭心脏中的PKM2特征
Biochem Biophys Res Commun. 2015 Apr 10;459(3):430-6. doi: 10.1016/j.bbrc.2015.02.122. Epub 2015 Feb 28.
10
Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.代谢效率促进了表达慢骨骼肌肌钙蛋白 I 的心脏对压力超负荷的保护。
Circ Heart Fail. 2015 Jan;8(1):119-27. doi: 10.1161/CIRCHEARTFAILURE.114.001496. Epub 2014 Nov 25.